Updated Jan 16, 2021 | 17:23 IST
The Resident Doctors' Association (RDA) of the Ram Manohar Lohia Hospital rejected Covaxin and requested the medical superintendent to vaccinate them with Oxford COVID-19 vaccine Covishield.
Oxford COVID-19 vaccine Covishield 
Key Highlights
'Covaxin manufactured by Bharat Biotech is being preferred in our hospital over Covishield manufactured by Serum Institute'
'The residents are a bit apprehensive about the lack of complete trial in case of Covaxin'
'We request you to vaccinate us with Covishield which has completed all stages of trial before its roll-out'
New Delhi: Rejecting Covaxin due to ‘lack of complete trial’, resident doctors of Ram Manohar Lohia Hospital requested the medical superintendent to vaccinate them with Oxford COVID-19 vaccine Covishield.